In prostate cancer-associated fibroblasts, activation of TRPA1 leads to increased Ca2+ levels and elevated hepatocyte growth factor (HGF) and vascular endothelial growth factor (VEGF) secretion. The gene discussed is TRPA1; the disease is prostate carcinoma.